Literature DB >> 30105628

Neuromuscular Junction Morphology and Gene Dysregulation in the Wobbler Model of Spinal Neurodegeneration.

Whitney A Ratliff1,2, Jessica N Saykally1,2, Michael J Kane1,2,3, Bruce A Citron4,5,6.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neuromuscular disease for which there is currently no effective treatment. The progression of ALS includes loss of motor neurons controlling the voluntary muscles, with much of this loss occurring at the neuromuscular junction. In an effort to better understand changes at the neuromuscular junction, we utilized the wobbler mouse model of motor neuron loss. We examined biceps and end plate morphologies and monitored selected factors involved in end plate function. Structural volumes were determined from 3D reconstructions that were generated for the end plates. Wobbler mice exhibited size reductions of both the muscle fibers and the end plates within the biceps, and we found that the end plate volumes were the most sensitive indicator of the degeneration. Concurrently, we found increases in calcitonin gene-related peptide (CGRP) and its receptor in wobbler biceps and spinal cord. We also found increases in gene expression of two acetylcholine receptors within the wobbler biceps, which may be a result of altered CGRP/CALCRL (calcitonin receptor-like receptor) expression.

Entities:  

Keywords:  Calcitonin gene-related peptide (CGRP); End plate; Motor neuron disease; Neuromuscular junction; Wobbler mice

Mesh:

Substances:

Year:  2018        PMID: 30105628      PMCID: PMC6684170          DOI: 10.1007/s12031-018-1153-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  1 in total

1.  Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis.

Authors:  Agustina Lara; Iván Esperante; Maria Meyer; Philippe Liere; Noelia Di Giorgio; Michael Schumacher; Rachida Guennoun; Gisella Gargiulo-Monachelli; Alejandro Federico De Nicola; Maria Claudia Gonzalez Deniselle
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.